Akira Matsuda

Hidaka, 3501298, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Deep learning-based morphological assessment of myelodysplastic syndrome on bone marrow smears.

Deep learning-based morphological assessment of myelodysplastic syndrome on bone marrow smears.

Journal: Leukemia research
Published: April 19, 2025

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.

Journal: British journal of haematology
Published: December 09, 2024

Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials.

Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials.

Journal: Annals of hematology
Published: November 12, 2024

Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study.

Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study.

Journal: British journal of haematology
Published: November 05, 2024

Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Journal: Blood advances
Published: September 18, 2024

Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.

Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.

Journal: British journal of haematology
Published: October 29, 2023

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.

Journal: Blood advances
Published: June 28, 2023

Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma

Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: April 30, 2023

Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma.

Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH
Published: January 04, 2022

Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution.

Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution.

Journal: American journal of clinical pathology
Published: November 26, 2021

Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan.

Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan.

Journal: Blood advances
Published: November 03, 2021

Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation.

Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation.

Journal: International journal of hematology
Published: October 31, 2021
Showing 1-12 of 48

Last Updated: 09/26/2026